|
|
Prepublished online as a Blood First Edition Paper on July 5, 2002; DOI 10.1182/blood-2002-03-0734.
Previous Article | Table of Contents | Next Article 
Blood, 15 November 2002, Vol. 100, No. 10, pp. 3656-3662
IMMUNOBIOLOGY
Lymphoproliferative defects in mice lacking the expression of
neurofibromin: functional and biochemical consequences of
Nf1 deficiency in T-cell development and
function
David A. Ingram,
Lei Zhang,
Jennifer McCarthy,
Mary Jo Wenning,
Lucy Fisher,
Feng-Chun Yang,
D. Wade Clapp, and
Reuben Kapur
From the Section of Neonatal-Perinatal Medicine,
Department of Pediatrics, Herman B. Wells Center for Pediatric Research
and the Department of Microbiology and Immunology, Indiana University
School of Medicine, Indianapolis, IN.
Ras plays an essential role in lymphocyte development and
function. However, in vivo consequence(s) of regulation of Ras activity by guanosine triphosphatase (GTPase)-activating proteins (GAPs) on
lymphocyte development and function are not known. In this study we
demonstrate that neurofibromin, the protein encoded by the
NF1 tumor suppressor gene functions as a GAP for Ras in T cells. Loss of Nf1 in T cells results in enhanced Ras
activation, which is associated with thymic and splenic
hyperplasia, and an increase in the absolute number of immature and
mature T-cell subsets compared with control mice. Interestingly, in
spite of a profound T-cell expansion and higher thymidine incorporation in unstimulated Nf1-deficient T cells, T-cell receptor and
interleukin-2 receptor-mediated proliferation of thymocytes and mature
T cells was substantially reduced compared with control mice.
Collectively, these results identify neurofibromin as a GAP for Ras in
T cells for maintaining immune homeostasis in vivo.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
F. Guo, J. A. Cancelas, D. Hildeman, D. A. Williams, and Y. Zheng
Rac GTPase isoforms Rac1 and Rac2 play a redundant and crucial role in T-cell development
Blood,
September 1, 2008;
112(5):
1767 - 1775.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Chen, Y. Qiu, L. Chen, L. Li, J. Chen, C. Zhang, B. Wang, Y. Yu, Z. Zhu, F. Zhu, et al.
The Expression of Neurofibromin in Human Osteoblasts and Chondrocytes
Ann. Clin. Lab. Sci.,
January 1, 2008;
38(1):
25 - 30.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Yang, W. Khalaf, L. van de Locht, J. H. Jansen, M. Gao, M. A. Thompson, B. A. van der Reijden, D. H. Gutmann, R. Delwel, D. W. Clapp, et al.
Transcriptional Repression of the Neurofibromatosis-1 Tumor Suppressor by the t(8;21) Fusion Protein
Mol. Cell. Biol.,
July 15, 2005;
25(14):
5869 - 5879.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. T. Le, N. Kong, Y. Zhu, J. O. Lauchle, A. Aiyigari, B. S. Braun, E. Wang, S. C. Kogan, M. M. Le Beau, L. Parada, et al.
Somatic inactivation of Nf1 in hematopoietic cells results in a progressive myeloproliferative disorder
Blood,
June 1, 2004;
103(11):
4243 - 4250.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|